| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
|
Nat Med
|
2006
|
6.18
|
|
2
|
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.
|
Cancer Cell
|
2006
|
4.13
|
|
3
|
Regulation of tumor angiogenesis by EZH2.
|
Cancer Cell
|
2010
|
3.10
|
|
4
|
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.
|
Cancer Res
|
2008
|
2.30
|
|
5
|
Pharmacodynamic markers of perifosine efficacy.
|
Clin Cancer Res
|
2007
|
2.28
|
|
6
|
PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway.
|
Invest New Drugs
|
2014
|
2.04
|
|
7
|
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.
|
J Clin Invest
|
2008
|
1.87
|
|
8
|
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.
|
Mol Cancer Ther
|
2011
|
1.81
|
|
9
|
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
|
Lancet Oncol
|
2011
|
1.65
|
|
10
|
Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.
|
Neoplasia
|
2007
|
1.29
|
|
11
|
Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.
|
AJR Am J Roentgenol
|
2012
|
1.28
|
|
12
|
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.
|
Cancer Res
|
2006
|
1.19
|
|
13
|
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.
|
Clin Cancer Res
|
2009
|
1.14
|
|
14
|
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
|
Cancer Res
|
2007
|
1.11
|
|
15
|
Imaging features of carcinoid tumors of the gastrointestinal tract.
|
AJR Am J Roentgenol
|
2013
|
1.10
|
|
16
|
Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model.
|
Radiology
|
2005
|
1.06
|
|
17
|
Imaging features of fibrolamellar hepatocellular carcinoma.
|
AJR Am J Roentgenol
|
2014
|
1.06
|
|
18
|
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
|
PLoS One
|
2009
|
1.06
|
|
19
|
Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality.
|
Radiographics
|
2011
|
0.99
|
|
20
|
Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.
|
AJR Am J Roentgenol
|
2015
|
0.97
|
|
21
|
Feasibility of multiple-mouse dynamic contrast-enhanced MRI.
|
Magn Reson Med
|
2007
|
0.95
|
|
22
|
Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.
|
PLoS One
|
2011
|
0.95
|
|
23
|
Diffusion weighted imaging in prostate cancer.
|
Eur Radiol
|
2010
|
0.95
|
|
24
|
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth.
|
Bone
|
2011
|
0.93
|
|
25
|
Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.
|
Cardiovasc Intervent Radiol
|
2011
|
0.91
|
|
26
|
Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer.
|
J Magn Reson Imaging
|
2008
|
0.90
|
|
27
|
Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI.
|
J Magn Reson Imaging
|
2010
|
0.90
|
|
28
|
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.
|
Gynecol Oncol
|
2012
|
0.89
|
|
29
|
Signaling can be uncoupled from imaging of the somatostatin receptor type 2.
|
Mol Imaging
|
2007
|
0.88
|
|
30
|
Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.
|
PLoS One
|
2011
|
0.88
|
|
31
|
Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study.
|
J Magn Reson Imaging
|
2011
|
0.86
|
|
32
|
Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases.
|
J Magn Reson Imaging
|
2009
|
0.86
|
|
33
|
In vivo functional and anatomic imaging for assessment of in vivo gene transfer.
|
Radiology
|
2009
|
0.85
|
|
34
|
Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model.
|
Radiology
|
2011
|
0.83
|
|
35
|
Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence.
|
Magn Reson Imaging
|
2013
|
0.82
|
|
36
|
Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough?
|
Neuroendocrinology
|
2011
|
0.81
|
|
37
|
Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model.
|
PLoS One
|
2013
|
0.79
|
|
38
|
Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model.
|
Technol Cancer Res Treat
|
2012
|
0.79
|
|
39
|
Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer.
|
Transl Oncol
|
2009
|
0.79
|
|
40
|
Imaging acute complications in cancer patients: what should be evaluated in the emergency setting?
|
Cancer Imaging
|
2014
|
0.78
|
|
41
|
Common and uncommon bilateral adult renal masses.
|
Cancer Imaging
|
2012
|
0.78
|
|
42
|
Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.
|
Mol Imaging
|
2013
|
0.78
|
|
43
|
Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model.
|
PLoS One
|
2010
|
0.78
|
|
44
|
Performance evaluation of iterative reconstruction algorithms for achieving CT radiation dose reduction - a phantom study.
|
J Appl Clin Med Phys
|
2016
|
0.77
|
|
45
|
Common and uncommon adult unilateral renal masses other than renal cell carcinoma.
|
Cancer Imaging
|
2012
|
0.76
|
|
46
|
Diagnostic approach to hereditary renal cell carcinoma.
|
AJR Am J Roentgenol
|
2015
|
0.76
|
|
47
|
Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells.
|
Lasers Surg Med
|
2014
|
0.76
|
|
48
|
Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT.
|
Abdom Imaging
|
2014
|
0.75
|
|
49
|
Visualizing the prostate gland by MR imaging in young and old mice.
|
PLoS One
|
2013
|
0.75
|
|
50
|
Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know.
|
AJR Am J Roentgenol
|
2012
|
0.75
|
|
51
|
Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors.
|
Nanotechnology
|
2015
|
0.75
|
|
52
|
Optical Characteristics and Tumor Imaging Capabilities of Near Infrared Dyes in Free and Nano-Encapsulated Formulations Comprised of Viral Capsids.
|
ACS Appl Mater Interfaces
|
2017
|
0.75
|
|
53
|
Biomimetic and bioinspired materials for applications in biophotonics.
|
J Biomed Opt
|
2014
|
0.75
|
|
54
|
Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction.
|
J Appl Clin Med Phys
|
2016
|
0.75
|